Evidence map›Paper›PMID 22807314›Full record

ArticleJournal of biochemical and molecular toxicology2012

Major differences among chemopreventive organoselenocompounds in the sustained elevation of cytoprotective genes.

Robyn L Poerschke, Michael R Franklin, Andrea H Bild, Philip J Moos

Abstract readComparative Study
In one paragraph

Article in Journal of biochemical and molecular toxicology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Effects of Mammalian Thioredoxin Reductase Inhibitors.Handbook of experimental pharmacology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Robyn L PoerschkeDepartment of Pharmacology and Toxicology, University of Utah College of Pharmacy, Salt Lake City, UT 84112, USA.
Michael R Franklin
Andrea H Bild
Philip J Moos
University of Utah · US

Funding

UTAH REGIONAL CANCER CENTERP30CA042014 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI KATHARINE S ULLMAN · 1986 to 2026
$72.6M
ADVANCES IN SELENIUM SUPPLEMENTATIONR01GM058913 · NIGMS · UNIVERSITY OF UTAH · PI FRANKLIN, MICHAEL ROGER · 2000 to 2006
$1.4M
The role of selenoproteins in the etiology of cancerR01CA115616 · NCI · UNIVERSITY OF UTAH · PI MOOS, PHILIP J · 2005 to 2008
$945k
Redox Mechanisms of Chemoprevention in Lung by Selenium SupplementationF31AT005041 · NCCIH · UNIVERSITY OF UTAH · PI POERSCHKE, ROBYN · 2009 to 2010
$61k
NCCIH NIH HHS F31 AT005041NCCIH NIH HHS F31AT005041-02NCI NIH HHS CA115616NCI NIH HHS P30 CA042014NCI NIH HHS R01 CA115616NIGMS NIH HHS GM058913NIGMS NIH HHS R01 GM058913
6 · The paper itself

Abstract

Cytoprotective enzyme elevation through the nuclear erythroid 2 p45-related factor 2 (Nrf2)-Kelch-like ECH-associated protein 1/antioxidant response element pathway has been promulgated for cancer prevention. This study compares the redox insult and sustained cytoprotective enzyme elevation by organoselenocompounds and sulforaphane (SF) in lung cells. SF elicited a rise in reactive oxygen species (ROS) and drop in glutathione (GSH) at 2 h; nuclear accumulation of Nrf2 at 4 h; and a GSH rebound and elevation in NAD(P)H quinone oxidoreductase (NQO1), thioredoxin reductase (TR1), and glutamate-cysteine ligase (GCL) at 24 h. Selenocystine (SECY) elicited a similar 24 h response, despite lesser earlier time-point changes. 2-Cyclohexylselenazolidine-4-carboxylic acid effects were similar to SECY's but with a larger Nrf2 change and the largest 24 h increase in GSH, GCL, TR1, and NQO1 of any compound investigated. Selenomethionine elicited a similar acute rise in ROS, but lesser depletion of GSH, no 4 h increase in nuclear Nrf2, only minor 24 h elevations in TR1 and NQO1, and a GCL elevation insufficient to elevate GSH.

Indexed as

Antioxidant Response ElementsAnticarcinogenic AgentsCell LineCytoprotectionGlutamate-Cysteine LigaseGlutathioneHumansIsothiocyanatesNAD(P)H Dehydrogenase (Quinone)NF-E2-Related Factor 2Organoselenium CompoundsOsteoprotegerinOxidation-ReductionProtein TransportSelenocysteineSelenomethionine2-cyclohexylselenazolidine-4-carboxylic acidAnticarcinogenic AgentsGlutamate-Cysteine LigaseGlutathioneIsothiocyanatesNAD(P)H Dehydrogenase (Quinone)NFE2L2 protein, humanNF-E2-Related Factor 2NQO1 protein, humanOrganoselenium CompoundsOsteoprotegerinSelenocysteineSelenomethioninesulforaphaneSulfoxidesThiocyanatesTNFRSF11B protein, human

Identifiers

PMID22807314
PMCPMC4551423
OpenAlexW1976039270

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.